EdgarLookup

CVR PARTNERS, LP — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that CVR PARTNERS, LP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
16.3%
Profit Margin
Net income ÷ revenue
10.2%
Return on Assets
Net income ÷ assets
+15.4%
Revenue Growth
Year over year

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $606.04M Feb 18, 2026
FY2025 Dec 31, 2024 $525.32M Feb 18, 2026
FY2025 Dec 31, 2023 $681.48M Feb 18, 2026
FY2024 Dec 31, 2022 $835.58M Feb 19, 2025
FY2023 Dec 31, 2021 $532.58M Feb 21, 2024
FY2022 Dec 31, 2020 $349.95M Feb 22, 2023
FY2019 Dec 31, 2019 $86.06M Feb 20, 2020
FY2019 Sep 30, 2019 $88.58M Feb 20, 2020
FY2019 Jun 30, 2019 $137.66M Feb 20, 2020
FY2019 Mar 31, 2019 $91.87M Feb 20, 2020

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $98.66M Feb 18, 2026
FY2025 Dec 31, 2024 $60.90M Feb 18, 2026
FY2025 Dec 31, 2023 $172.43M Feb 18, 2026
FY2024 Dec 31, 2022 $286.80M Feb 19, 2025
FY2023 Dec 31, 2021 $78.16M Feb 21, 2024
FY2022 Dec 31, 2020 ($98.18M) Feb 22, 2023
FY2019 Dec 31, 2019 ($24.88M) Feb 20, 2020
FY2019 Sep 30, 2019 ($22.98M) Feb 20, 2020
FY2019 Jun 30, 2019 $18.97M Feb 20, 2020
FY2019 Mar 31, 2019 ($6.08M) Feb 20, 2020

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $128.66M Feb 18, 2026
FY2025 Dec 31, 2024 $90.35M Feb 18, 2026
FY2025 Dec 31, 2023 $201.41M Feb 18, 2026
FY2024 Dec 31, 2022 $319.91M Feb 19, 2025
FY2023 Dec 31, 2021 $134.48M Feb 21, 2024
FY2022 Dec 31, 2020 ($34.88M) Feb 22, 2023
FY2019 Dec 31, 2019 ($9.09M) Feb 20, 2020
FY2019 Sep 30, 2019 ($7.52M) Feb 20, 2020
FY2019 Jun 30, 2019 $34.54M Feb 20, 2020
FY2019 Mar 31, 2019 $9.44M Feb 20, 2020

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $33.59M Feb 18, 2026
FY2025 Dec 31, 2024 $28.41M Feb 18, 2026
FY2025 Dec 31, 2023 $29.52M Feb 18, 2026
FY2024 Dec 31, 2022 $32.19M Feb 19, 2025
FY2023 Dec 31, 2021 $26.62M Feb 21, 2024
FY2022 Dec 31, 2020 $18.17M Feb 22, 2023
FY2021 Dec 31, 2019 $25.83M Feb 23, 2022
FY2020 Dec 31, 2018 $25.02M Feb 23, 2021
FY2017 Dec 31, 2017 $6.88M Feb 23, 2018
FY2017 Sep 30, 2017 $6.08M Feb 23, 2018

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $149.64M Feb 18, 2026
FY2025 Dec 31, 2024 $150.54M Feb 18, 2026
FY2025 Dec 31, 2023 $243.53M Feb 18, 2026
FY2024 Dec 31, 2022 $301.46M Feb 19, 2025
FY2023 Dec 31, 2021 $188.73M Feb 21, 2024
FY2022 Dec 31, 2020 $19.74M Feb 22, 2023
FY2021 Dec 31, 2019 $39.16M Feb 23, 2022
FY2020 Dec 31, 2018 $32.23M Feb 23, 2021
FY2019 Dec 31, 2017 $10.40M Feb 20, 2020
FY2018 Dec 31, 2016 $44.97M Feb 21, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $969.46M Feb 18, 2026
FY2025 Dec 31, 2024 $1.02B Feb 18, 2026
FY2024 Dec 31, 2023 $975.33M Feb 19, 2025
FY2023 Dec 31, 2022 $1.10B Feb 21, 2024
FY2022 Dec 31, 2021 $1.13B Feb 22, 2023
FY2021 Dec 31, 2020 $1.03B Feb 23, 2022
FY2020 Dec 31, 2019 $1.14B Feb 23, 2021
FY2019 Jan 1, 2019 $1.27B Feb 20, 2020
FY2019 Dec 31, 2018 $1.25B Feb 20, 2020
FY2018 Dec 31, 2017 $1.23B Feb 21, 2019

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2022 $0 Feb 22, 2023
FY2022 Dec 31, 2021 $0 Feb 22, 2023
FY2021 Dec 31, 2020 $0 Feb 23, 2022
FY2020 Dec 31, 2019 $40.97M Feb 23, 2021
FY2019 Dec 31, 2018 $40.97M Feb 20, 2020
FY2018 Dec 31, 2017 $40.97M Feb 21, 2019
FY2017 Dec 31, 2016 $40.97M Feb 23, 2018
FY2016 Dec 31, 2015 $40.97M Feb 21, 2017
FY2015 Dec 31, 2014 $40.97M Feb 18, 2016
FY2014 Dec 31, 2013 $40.97M Feb 20, 2015

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $69.24M Feb 18, 2026
FY2025 Dec 31, 2024 $90.86M Feb 18, 2026
FY2024 Dec 31, 2023 $45.28M Feb 19, 2025
FY2023 Dec 31, 2022 $86.34M Feb 21, 2024
FY2022 Dec 31, 2021 $112.52M Feb 22, 2023
FY2021 Dec 31, 2020 $30.56M Feb 23, 2022
FY2020 Dec 31, 2019 $36.99M Feb 23, 2021
FY2019 Dec 31, 2018 $61.78M Feb 20, 2020
FY2018 Dec 31, 2017 $49.17M Feb 21, 2019
FY2018 Dec 31, 2016 $55.60M Feb 21, 2019

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2020 Dec 31, 2020 $636.18M Feb 23, 2021
FY2020 Dec 31, 2019 $632.41M Feb 23, 2021
FY2018 Dec 31, 2018 $628.99M Feb 21, 2019
FY2018 Dec 31, 2017 $625.90M Feb 21, 2019

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 9 Feb 18, 2026
FY2025 Dec 31, 2024 5 Feb 18, 2026
FY2025 Dec 31, 2023 16 Feb 18, 2026
FY2024 Dec 31, 2022 27 Feb 19, 2025
FY2023 Dec 31, 2021 7 Feb 21, 2024
FY2022 Dec 31, 2020 (8) Feb 22, 2023
FY2021 Dec 31, 2019 (3) Feb 23, 2022
FY2017 Dec 31, 2017 0 Feb 23, 2018
FY2016 Dec 31, 2016 0 Feb 21, 2017
FY2016 Sep 30, 2016 0 Feb 21, 2017

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 9 Feb 18, 2026
FY2025 Dec 31, 2024 5 Feb 18, 2026
FY2025 Dec 31, 2023 16 Feb 18, 2026
FY2024 Dec 31, 2022 27 Feb 19, 2025
FY2023 Dec 31, 2021 7 Feb 21, 2024
FY2022 Dec 31, 2020 (8) Feb 22, 2023
FY2021 Dec 31, 2019 (3) Feb 23, 2022
FY2017 Dec 31, 2017 0 Feb 23, 2018
FY2016 Dec 31, 2016 0 Feb 21, 2017
FY2016 Sep 30, 2016 0 Feb 21, 2017